基本信息
浏览量:49
职业迁徙
个人简介
Arpad Szallasi is a leading expert on the roles of TRP channels in health and disease. He was the first to provide a biochemical proof for the existence of the vanilloid (capsaicin) receptor, now known as TRPV1.
Arpad Szallasi held several research positions both in academia (Karolinska Institute, Washington University, St. Louis, MO) and industry (Menarini Ricerche Sud, Pomezia, Italy) before pursuing a carrier in diagnostic pathology. He is a diplomate of the American Board of Pathology.
Arpad Szallasi holds four US patents on the use of resiniferatoxin for therapeutic purposes. He has served as a scientific advisor to several biotech companies, and was involved in the development of four TRP channel antagonists advanced into clinical trials.
研究兴趣
论文共 574 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CURRENT OPINION IN PHARMACOLOGY (2024): 102447-102447
International Journal of Molecular Sciencesno. 1 (2024): 320
Wei Hu,Thomas Wartmann, Marco Strecker,Aristotelis Perrakis,Roland Croner,Arpad Szallasi,Wenjie Shi, Uli Kahlert
ONCOLOGY RESEARCHno. 1 (2024): 227-240
Temperature (Austin, Tex.)no. 1 (2023): 1-2
International journal of molecular sciencesno. 10 (2023)
International journal of molecular sciencesno. 20 (2023): 15042-15042
Temperature (Austin, Tex.)no. 1 (2023): 3-8
International journal of molecular sciencesno. 10 (2023): 9098-9098
Biomoleculesno. 6 (2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn